| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Lyons Gary A is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $23.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $152.61 | $2,289,082.50 | -11.1% | -13.7% | - | |
| Oct 4, 2024 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 40,000 | $14.73 | $589,100.78 | -24.9% | +24.6% | +61.8% | |
| Aug 13, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 11,570 | $150.43 | $1,740,449.65 | -8.9% | -15.6% | -12.7% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 930 | $150.03 | $139,530.23 | -0.8% | -21.0% | -9.5% | |
| May 14, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 12,500 | $135.63 | $1,695,370.00 | -9.7% | +6.4% | -14.2% | |
| Dec 22, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $130.04 | $1,300,443.00 | -4.9% | +11.9% | +5.4% | |
| Dec 1, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 5,000 | $116.77 | $583,837.00 | -2.4% | +11.3% | +8.2% | |
| Sep 12, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 5,000 | $115.02 | $575,120.00 | -2.4% | +1.2% | +3.7% | |
| Sep 1, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 5,000 | $110.06 | $550,315.50 | -2.4% | +5.4% | +14.9% | |
| Oct 31, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $114.76 | $1,721,403.00 | -6.9% | -5.9% | -3.6% |